Monitor for immediate ATM drawdowns or follow-on offerings given the company's urgent capital needs and low market cap. Any near-term issuance will be highly dilutive to existing shareholders.
Price Chart
Executive Summary
Cue Biopharma's S-3 shelf registration has become effective, allowing the company to raise up to $300 million through various offerings, including a $12.67 million at-the-market (ATM) program with Jefferies. Given the company's $22 million market cap and prior disclosure of substantial doubt about its going concern status, this creates immediate dilution risk.
Key Facts
- S-3 shelf registration became effective on 2026-03-31
- Authorization to raise up to $300 million in securities
- Includes a specific $12.67 million ATM offering with Jefferies
- Company has a market cap of $22 million and only $27.1 million in cash
- Previously disclosed substantial doubt regarding going concern
Financial Impact
$300 million in potential dilution overhang; $12.67 million ATM offering immediately available
Risk Factors
- High dilution risk due to large shelf size relative to $22 million market cap
- Going concern uncertainty increases pressure to raise capital quickly
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001020 |
| Document: 9999999995-26-001020-index.html | 9999999995-26-001020 |
| Document: 9999999995-26-001020.txt | 9999999995-26-001020 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | Insider Cluster | $18.67 $16.71 | ▲ +10.50% | ▲ +9.39% | $18.32 (+1.87%) |
Oct 13, 2026 13d ago | 144 | $18.60 $18.67 | ▲ +0.38% | ▲ +0.09% | $18.32 (−1.51%) |
Oct 8, 2026 19d ago | SC 13G/A | $22.33 $27.66 | ▲ +23.87% | ▲ +23.27% | $18.32 (−17.96%) |
Sep 21, 2026 5w ago | 8-K | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.32 (−35.20%) |
Sep 20, 2026 5w ago | Press Release | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.32 (−35.20%) |
Aug 21, 2026 9w ago | EFFECT | $23.98 $23.18 | ▲ +3.34% | ▲ +3.04% | $18.32 (+23.60%) |
Aug 17, 2026 10w ago | Insider Cluster | $25.70 $26.28 | ▼ −2.26% | ▼ −2.05% | $18.32 (+28.72%) |
Aug 14, 2026 10w ago | Press Release | $27.64 $25.70 | ▼ −7.02% | ▼ −6.34% | $18.32 (−33.72%) |
Aug 13, 2026 10w ago | 144 | $34.20 $27.64 | ▼ −19.18% | ▼ −18.71% | $18.32 (−46.43%) |
Jul 9, 2026 15w ago | Press Release | $36.78 $30.92 | ▼ −15.93% | ▼ −15.17% | $18.32 (−50.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers